Evidence map›Paper›PMID 15548369›Full record

ArticleNeoplasia (New York, N.Y.)

Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing.

Andreas Kurtz, Achim Aigner, Rafael H Cabal-Manzano, Robert E Butler, Dozier R Hood, Roy B Sessions, Frank Czubayko, Anton Wellstein

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of FGF-binding protein 3 on vascular permeability.The Journal of biological chemistry · 2008
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andreas KurtzLombardi Cancer Center, Department of Oncology, Georgetown University, Washington, DC 20057, USA.
Achim Aigner
Rafael H Cabal-Manzano
Robert E Butler
Dozier R Hood
Roy B Sessions
Frank Czubayko
Anton Wellstein
Georgetown University · USGeorgetown University Medical Center · US

Funding

BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGFR01CA071508 · NCI · GEORGETOWN UNIVERSITY · PI WELLSTEIN, ANTON · 1997 to 2010
$2.9M
Inhibition of the ALK Receptor KinaseR01CA101811 · NCI · GEORGETOWN UNIVERSITY · PI WELLSTEIN, ANTON · 2003 to 2006
$1.6M
NCI NIH HHS R01 CA071508NCI NIH HHS R01 CA101811NCI NIH HHS R01 CA71508
6 · The paper itself

Abstract

The initiation of premalignant lesions is associated with subtle cellular and gene expression changes. Here we describe a severe combined immunodeficiency mouse xenograft model with human adult skin and compare chemical carcinogenesis and wound healing. We focus on a secreted binding protein for fibroblast growth factors (FGF-BP) that enhances the activity of locally stored FGFs and is expressed at high levels in human epithelial cancers. Carcinogen treatment of murine skin induced papilloma within 6 weeks, whereas the human skin grafts displayed no obvious macroscopic alterations. Microscopic studies of the human skin, however, showed p53-positive keratinocytes in the epidermis, increased angiogenesis in the dermis of the treated skin, enhanced proliferation of keratinocytes in the basal layer, and an increase of FGF-BP protein and mRNA expression. In contrast, after surgical wounding of human skin grafts or of mouse skin, FGF-BP expression was upregulated within a few hours and returned to control levels after 2 days with wound closure. Enhanced motility of cultured keratinocytes and dermal fibroblasts by FGF-BP supports a role in wound healing. We conclude that adult human skin xenografts can be used to identify early molecular events during malignant transformation as well as transient changes during wound healing.

Indexed as

Cell Transformation, NeoplasticWound Healing9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogensCarrier ProteinsCell ProliferationHumansIntercellular Signaling Peptides and ProteinsMiceMice, SCIDNeovascularization, PathologicPapillomaProliferating Cell Nuclear AntigenSkinSkin Neoplasms9,10-Dimethyl-1,2-benzanthraceneCarcinogensCarrier ProteinsFGFBP1 protein, humanIntercellular Signaling Peptides and ProteinsProliferating Cell Nuclear AntigenTetradecanoylphorbol AcetateTumor Suppressor Protein p53

Identifiers

PMID15548369
PMCPMC1531664
OpenAlexW2007692648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.